TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change From Baseline in Trauma-related Guilt Distress at Post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change From Baseline in Trauma-related Shame at Post-treatment Follow-up
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Final Utility Index of EQ-5D Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean Change in Pain Intensity Scores (NRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Change in Pain Intensity Scores (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time From Foley Bulb Placement to Time of Delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Delivery of Trial of Labor After Cesarean Section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 Minute Apgar Score of Trial of Labor After Cesarean Section
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported Treatment Retention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean weekly blood glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain Visual Analog Scale (VAS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nausea Score on VAS Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response Rate (Complete Response Plus Partial Response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change From Baseline in ADAS-cog+
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean Intact Parathyroid Hormone (iPTH) Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Apoptotic Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Imaging Quality Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Superficial incisional surgical site infections
Endpoint domain: Adverse events/effects
Primary endpoint: Success rate of fiducial marker placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Time With Sensed Glucose Between 70-180 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Progression-Free Survival (PFS6)
Endpoint domain: Mortality/survival
Primary endpoint: Time between MRI and decision of intensive care continuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and timing of skeletal-related events (SREs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with solicited injection site and systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 2 or higher Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Bone Bio-marker Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in the Alzheimer's Disease Assessment Scale-cognitive subscale (ADAS-cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in the ADCS-Clinician's Global Impression of Change (CGIC)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Colorectal cancer detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Breast cancer detection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Aortic valve replacement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: In-Hospital Mortality
Endpoint domain: Mortality/survival
Primary endpoint: Change of Episodes Inappropriately Treated by Shock Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from baseline Atelectasis scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline cardiac frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Sternal Healing Score at 3 Month Post op
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Sternal Healing Score at 6 Month Post op
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in modified Marshall score on Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in CTSI Score on Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of infection to severe sepsis
Endpoint domain: Mortality/survival
Primary endpoint: exercise tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VO2 kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Brow Elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent reduction in GERD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of objects detected on the roadway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC [0-tau]) of TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Concentration (Cmax) of TAF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration at the End of the Dosing Interval (Ctau) of FTC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interstitial fibrosis assessed by MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clot Degradation at 24 Hours Post-operatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Magnitude of prosthetic socket rotation and slip
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Doctor Patient Communication score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Range of motion of arm elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of range of motion of arm elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor control during functional task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Factor IX Activity Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: degree of pain experienced during the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in engagement in discussion of living and deceased donor transplantation
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in knowledge of living and deceased donor transplant
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Microglial activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Global Response Assessment for vulvar pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Serum Concentration of cTnI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Coronary Artery Calcification-score progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cancer-induced malnutrition treatment effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percent Change From Baseline in Total Nasal Symptom Score (TNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Child's Postural control and balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: myometrial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate after induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Degree of Occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rethrombosis
Endpoint domain: Adverse events/effects
Primary endpoint: Incontinence score using St' Mark's (Vaiszey)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of death, myocardial infarction, stroke or major bleeding
Endpoint domain: Mortality/survival
Primary endpoint: Doubling of Serum Creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: End-stage Kidney Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Renal or Cardiovascular Death
Endpoint domain: Mortality/survival
Primary endpoint: plaque score levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probing pocket depths
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probing attachment levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hematological malignancies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of subjects with plasma HIV RNA levels below the limit of quantification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until loss of virologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S-25-hydroxyvitamin D in nmol/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grip strength in Newton
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper leg strength, able or not able to squat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loco regional progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of Children Maintaining Normal Growth Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Body Lean Body Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total Body Water
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Negative Change in Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Degree of hemolysis of G6PD(-) red blood cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants affected by an adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Change in executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of participants missing questionnaires
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Follow-up response rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of consented patients who remain on the study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Troponins I variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial VO2 and O2 extraction variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Lactates variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Duration of functional loss of C- and A-delta-fibres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Extent of functional loss of C- and A-delta-fibres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Life impact of Pelvic Floor Dysfunction (PFD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Symptoms and Quality of life (QoL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of Pelvic Floor Muscle (PFM) strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type, incidence, severity, timing, seriousness and relatedness of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: range of pain-free passive ankle joint dorsiflexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plantar heel tenderness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disability imposed by heel pain/plantar fasciitis
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Degree of difficulty in attaching the harness
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reported occurrences of subject discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of ECG tracings during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants in Clinical Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-resuscitation temperature at 30 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of procedures performed to newborns while on the BabySaver kit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in post-resuscitation temperature at admission to Neonatal unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete Response Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diastolic function (E/A ratio)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Survival at 60 days
Endpoint domain: Mortality/survival
Primary endpoint: Electrophysiological study findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rotator cuff tear healing rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prevalence of Microfilaria in Blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time to resolution of chylothorax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Symptom Score (MSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in cellular measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline in molecular measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in the expression on mDCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clinical Response Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Standardised measure of visual neglect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: absence of binary restenosis (≥ 50% re-obstruction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Number of Participants Experiencing Any of the Adjudicated Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Clinical Laboratory Parameters (Chloride, Potassium and Sodium)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain measures of mental workload (ERP 300 amplitude and latency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: progression-free survival at 4-months
Endpoint domain: Mortality/survival
Primary endpoint: Change in Skin Thickness of the Calf
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Tampa Scale for Kinesiophobia (change)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain Catastrophizing Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thymoma staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Grade 3 or 4 Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative Opiate consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change From Baseline in Hemoglobin A1C at Week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change From Baseline in A1C at Week 54
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: economic behaviour
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: sexual behaviour
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Self-selected Overground Walking Speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discoloration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Diagnostic accuracy of EDTU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MIC distribution of microorganisms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in the Sino-nasal-outcome test SNOT-20
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression free survival (PFS) at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of Participants with Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean Score of the Caregivers' Rating of Neupro®
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Score of the Physicians' Rating of Neupro®
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median time to achieving gravity gradient of 90°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial Blood Flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in baseline cardiac stroke volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tooth sensitivity during procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnoses of GERD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Prescriptions for gastroprotective medicines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in attitudes towards behavioral health treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initiation to behavioral health treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to confirmed progression of at least one EDSS point
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Change in mean intra-operative radiation exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Encounter Profile (SEP) questions 2 and 3
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression of CKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Tobacco Susceptibility
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage Correct on Word Identification Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left Ventricular End Systolic Volume (LVESV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Epithelial and subepithelial thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Significant mean percent change in TILs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Bowel related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effect of paracetamol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Atopic Dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateralisation of cortisol overproduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Health-Related Quality of Life (HRQoL) of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Control of Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Control Of Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Progression-free Survival (PFS) at 4 Months
Endpoint domain: Mortality/survival
Primary endpoint: Academic Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression, Anxiety and Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ability to participate in social roles and activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Optimal cut-off score of ID Pain-T Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fall Injury
Endpoint domain: Adverse events/effects